المؤلفون: Takaaki Kitayama, Ryota Otoshi, Katsuyuki Higa, Tomohisa Baba, Takafumi Yamaya, Satoshi Ikeda, Ryo Okuda, Eri Hagiwara, Hideya Kitamura, Erina Tabata, Takashi Niwa, Tsuneyuki Oda, Shigeru Komatsu, Hiroko Okabayashi, Yozo Sato, Takashi Ogura, Ryota Shintani, Kota Murohashi, Atsuhito Nakazawa, Akiamasa Sekine

المصدر: Journal of Infection and Chemotherapy

مصطلحات موضوعية: Male, 0301 basic medicine, Multivariate analysis, BMI, body mass index, Lymphocyte, Disease, Respiratory failure, Severity of Illness Index, 0302 clinical medicine, Japan, FiO2, fraction of inspired oxygen, Medicine, Pharmacology (medical), 030212 general & internal medicine, COVID-19, coronavirus disease 2019, Aged, 80 and over, Medical record, Age Factors, list: AST, aspartate aminotransferase, Middle Aged, SARS-CoV-2, severe acute respiratory syndrome coronavirus2, C-Reactive Protein, Infectious Diseases, medicine.anatomical_structure, CRP, C-reactive protein, Original Article, Female, Adult, Microbiology (medical), medicine.medical_specialty, 030106 microbiology, macromolecular substances, AUC, area under curve, Severity, 03 medical and health sciences, Internal medicine, Severity of illness, Humans, Aspartate Aminotransferases, Lymphocyte Count, Aged, Retrospective Studies, LDH, Lactate dehydrogenase, L-Lactate Dehydrogenase, SARS-CoV-2, business.industry, SpO2, saturation of percutaneous oxygen, COVID-19, Retrospective cohort study, PaO2, pressure of oxygen, ROC, receiver operating characteristic, Coronavirus, business, ECMO, extracorporeal membrane oxygenation, Body mass index

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b469e31a8606cf4ed6c0b34983804c73Test
https://doi.org/10.1016/j.jiac.2021.02.028Test

المؤلفون: Negar Khalili, Mohamad Amin Pourhoseingholi, Ilad Alavi Darazam, Azam Soleymaninia, Latif Gachkar, Akram Hoseyni Kusha, Mohammad Mahdi Rabiei, Minoosh Shabani, Legha Lotfollahi, Mahdi Amirdosara, Firouze Hatami, Parham Torabinavid, Omid Moradi, Mohammadreza Hajiesmaeili, Ali Khoshkar, Masoud Mardani, Hadiseh Shabanpour Dehbsneh, Maryam Taleb Shoushtari, Omidvar Rezaei, Seyed Sina Naghibi Irvani, Shervin Shokouhi, Farid Javandoust Gharehbagh

المصدر: International Immunopharmacology

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Indoles, Immunology, Population, Antiviral Agents, Article, Lopinavir, law.invention, Shahid, COVID-2019, Coronavirus Disease 2019, Randomized controlled trial, law, Informed consent, Internal medicine, medicine, Immunology and Allergy, Humans, education, TTCI, Time to clinical improvement, Aged, Pharmacology, education.field_of_study, Ritonavir, Umifenovir, business.industry, SARS-CoV-2, LFT, liver function test, Arbidol, Hazard ratio, COVID-19, Middle Aged, ABG, Atrial blood gas, COVID-19 Drug Treatment, Clinical trial, SARS-CoV-2, severe acute respiratory syndrome coronavirus2, ICU, Intensive care unit, HR, Hazard Ratio, GCS, Glasgow Coma Scale, Drug Therapy, Combination, Female, business, VBG, Venous blood gas, Interferon beta-1a, medicine.drug, Hydroxychloroquine

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de0a469b2ff51e1cb6c0120853acba1fTest
http://europepmc.org/articles/PMC8270750Test